Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ENDRA Life Sciences Says Following The Special Meeting, Board Approved Reverse Stock Split Ratio Of 1-For-30; Says Co. Intends To Effect Split Prior To Dec. 31, 2022

Author: Michael Horton | December 02, 2022 05:16pm

-SEC Filing

Posted In: NDRA